168 related articles for article (PubMed ID: 34679349)
1. Pro-Inflammatory Cytokines and Antibodies Induce hnRNP A1 Dysfunction in Mouse Primary Cortical Neurons.
Li M; Hamilton R; Salapa HE; Levin MC
Brain Sci; 2021 Sep; 11(10):. PubMed ID: 34679349
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis.
Libner CD; Salapa HE; Hutchinson C; Lee S; Levin MC
J Comp Neurol; 2020 Jul; 528(10):1704-1724. PubMed ID: 31872424
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple Sclerosis.
Douglas JN; Gardner LA; Salapa HE; Levin MC
J Clin Cell Immunol; 2016 Apr; 7(2):402. PubMed ID: 27375925
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity to a ribonucleoprotein drives neuron loss in multiple sclerosis models.
Libner CD; Salapa HE; Hutchinson C; Stang TE; Thibault PA; Hammond SA; Levin MC
Neurobiol Dis; 2022 Aug; 170():105775. PubMed ID: 35618205
[TBL] [Abstract][Full Text] [Related]
5. Neuronal RNA-binding protein dysfunction in multiple sclerosis cortex.
Salapa HE; Hutchinson C; Popescu BF; Levin MC
Ann Clin Transl Neurol; 2020 Jul; 7(7):1214-1224. PubMed ID: 32608162
[TBL] [Abstract][Full Text] [Related]
6. Dysfunctional RNA binding proteins and stress granules in multiple sclerosis.
Salapa HE; Johnson C; Hutchinson C; Popescu BF; Levin MC
J Neuroimmunol; 2018 Nov; 324():149-156. PubMed ID: 30190085
[TBL] [Abstract][Full Text] [Related]
7. Dysfunctional RNA-binding protein biology and neurodegeneration in experimental autoimmune encephalomyelitis in female mice.
Salapa HE; Libner CD; Levin MC
J Neurosci Res; 2020 Apr; 98(4):704-717. PubMed ID: 31755578
[TBL] [Abstract][Full Text] [Related]
8. hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis.
Jahanbazi Jahan-Abad A; Salapa HE; Libner CD; Thibault PA; Levin MC
Glia; 2023 Mar; 71(3):633-647. PubMed ID: 36382566
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.
Douglas JN; Gardner LA; Salapa HE; Lalor SJ; Lee S; Segal BM; Sawchenko PE; Levin MC
J Neuroinflammation; 2016 Jul; 13(1):178. PubMed ID: 27391474
[TBL] [Abstract][Full Text] [Related]
10. Knock-Down of Heterogeneous Nuclear Ribonucleoprotein A1 Results in Neurite Damage, Altered Stress Granule Biology, and Cellular Toxicity in Differentiated Neuronal Cells.
Anees A; Salapa HE; Thibault PA; Hutchinson C; Hammond SA; Levin MC
eNeuro; 2021; 8(6):. PubMed ID: 34697074
[TBL] [Abstract][Full Text] [Related]
11. hnRNP A1 dysfunction alters RNA splicing and drives neurodegeneration in multiple sclerosis (MS).
Salapa HE; Thibault PA; Libner CD; Ding Y; Clarke JWE; Denomy C; Hutchinson C; Abidullah HM; Austin Hammond S; Pastushok L; Vizeacoumar FS; Levin MC
Nat Commun; 2024 Jan; 15(1):356. PubMed ID: 38191621
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the Degeneration of the Neuro-Axonal Unit to the Pathogenesis of Multiple Sclerosis.
Salapa HE; Lee S; Shin Y; Levin MC
Brain Sci; 2017 Jun; 7(6):. PubMed ID: 28629158
[TBL] [Abstract][Full Text] [Related]
13. A potential link between autoimmunity and neurodegeneration in immune-mediated neurological disease.
Lee S; Xu L; Shin Y; Gardner L; Hartzes A; Dohan FC; Raine C; Homayouni R; Levin MC
J Neuroimmunol; 2011 Jun; 235(1-2):56-69. PubMed ID: 21570130
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles.
Bekenstein U; Soreq H
Mol Cell Neurosci; 2013 Sep; 56():436-46. PubMed ID: 23247072
[TBL] [Abstract][Full Text] [Related]
15. Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation.
Clarke JWE; Thibault PA; Salapa HE; Kim DE; Hutchinson C; Levin MC
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809384
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Salapa H
J Neuroimmunol; 2017 Mar; 304():56-62. PubMed ID: 27449854
[TBL] [Abstract][Full Text] [Related]
17. Methylarginines within the RGG-Motif Region of hnRNP A1 Affect Its IRES Trans-Acting Factor Activity and Are Required for hnRNP A1 Stress Granule Localization and Formation.
Wall ML; Lewis SM
J Mol Biol; 2017 Jan; 429(2):295-307. PubMed ID: 27979648
[TBL] [Abstract][Full Text] [Related]
18. Modulation of AUUUA response element binding by heterogeneous nuclear ribonucleoprotein A1 in human T lymphocytes. The roles of cytoplasmic location, transcription, and phosphorylation.
Hamilton BJ; Burns CM; Nichols RC; Rigby WF
J Biol Chem; 1997 Nov; 272(45):28732-41. PubMed ID: 9353343
[TBL] [Abstract][Full Text] [Related]
19. Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements.
Black AC; Luo J; Watanabe C; Chun S; Bakker A; Fraser JK; Morgan JP; Rosenblatt JD
J Virol; 1995 Nov; 69(11):6852-8. PubMed ID: 7474099
[TBL] [Abstract][Full Text] [Related]
20. Altered mRNP granule dynamics in FTLD pathogenesis.
Bowden HA; Dormann D
J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
